This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A number of studies have been done to characterize HIV-1 in semen from HIV-1 subtype B-infected subjects and its role in disease progression. However, no studies have been done to date on the characterization of HIV-1 in semen in non-B-infected subjects, although there are some indications that blood and seminal viral load may be higher in subtype C infection compared to subtype B infections. Higher levels of HIV-1 subtype C in semen may help to explain the rapid spread of the epidemic in areas of the world where subtype C is most prevalent. India with predominant type C provides an excellent opportunity to charcaterize the HIV-1in semen and its role in pathogenesis in subtype C-infected subjects. Furthermore, HIV-1 from India are genetically and phenotypically different than those present in US. This raises the possibility that viral dynamics of HIV-1 in various body compartments in subtype C-infected subjects in India are different than those in subtype B infected subjects in western countries. Therefore we hypothesize that the role of viral load in semen in disease development and compartmentalization of HIV-1 between semen and blood will be different in subtype C-infected subjects than subtype B infected subjects. Our overall objective is to characterize HIV-1 in semen in HIV-infected subjects from India. Specifically, we propose to compare viral variants present in semen and blood from HIV-infected subjects from India. Viral variants present in seminal mononuclear cells and seminal fluids will be separately analyzed and compared with those present in blood plasma and mononuclear cells by examining the sequences of the C2-V5 region of gp120 of HIV-1 RNA. Semen and blood plasma and mononuclear cells samples collected through our collaborative study in India will be used in this project.
Showing the most recent 10 out of 292 publications
